"In the emerging markets arena, India frequently plays second-fiddle to China; but investors should not be deceived: India offers plenty of opportunities, such as Tata Motors (TTM)," says Brandon Clay.

The editor of Invest with an Edge explains "Tata is India's top automaker and the owner of the Jaguar and Land Rover luxury brands.

"India is the second-largest country in the world by population. It's also growing fast, but not as fast as China. The government wants to see annual economic growth top 10%. That's good stuff.

"The fallout from plunging oil prices and Europe's sovereign debt crisis has given investors few places to hide; however, one asset class that can be seen as safe haven is gold-related investments -- and the current pullback could be a good buying opportunity," suggests Brandon Clay.

The editor of Invest with an Edge explains, "The Market Vectors Junior Gold Miners ETF (GDXJ) has outperformed its larger rivals since its debut last November.

"The ETF has proven popular with investors; since it came public it has accumulated almost $116 million in assets. That's an impressive haul in such short time.

"With sugar prices rising, our latest stock pick is the Brazilian ethanol and sugar producer Cosan Limited (CZZ)," says Brandon Clay. Here's the latest update from Invest with an Edge.

"Like all commodities, sugar prices are affected by the worldwide supply and demand of sugar. When there's a glut of sugar, prices fall. When sugar crops are threatened or supply is tight, sugar futures rise. That's what is happening now.

This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.

"Oil recently suffered a pullback, but we think it's temporary," says Brandon Clay, who turns to the oil sector for his top pick for 2010.

The editor of Invest with an Edge suggests, "One stock that should pull out of congestion when energy moves again in 2010 is Oceaneering International (OII), a company involved in deep-water drilling services.

"Shanda Interactive, a Chinese purveyor of interactive entertainment and media technology, offered U.S. investors a piece of its video game business, Shanda Games (NASDAQ: GAME)," notes Brandon Clay.

In his Invest with an Edge, he explains, "Shanda Games has its risks but also packs a lot of potential, especially as a speculative China play.

"GAME was one of the most widely-anticipated IPOs of 2009. The buzz surrounding Shanda Games was so intense that the company raised the offering from 63 million to 83.5 million shares just to meet demand.

"Banks had taken a brutal beating over the last two years was brutal; the S&P Sector SPDR Financials dropped 72.0% from its high last September to its low in March," notes Brandon Clay.

In his Invest with an Edge, he explains, "One bank in particular is exerting itself again as a dominant player: Wells Fargo & Company (NYSE: WFC)." Here's his review.

"The painful declines in bank stocks appear to have stopped for now, as bank stocks have exploded off the March lows. As we've observed, financials have 'friends in high places.'

"Banks in general are showing promise as credit becomes easier. There's still a long way to go for complete recovery, but the trend is pointing up.

"Some sectors tend to do better than others in tough times; biotechnology often surprises investors in good times and bad," suggests Brandon Clay.

In his Invest with an Edge advisory service, the growth stock advisor looks to Celgene Corporation (NASDAQ: CELG), a player in developing cancer treatments. Here's his review.

"This sometimes-perilous market niche can make or break a portfolio depending on several factors: drug pipeline, continued investment, market factors, and government approvals.

"However, despite the risks, there are times when we believe that individual biotech stocks make sense -- such as our latest recommendation for Celgene.

"Microsoft (NASDAQ: MSFT) is a well-run company with a fortress-like balance sheet," says growth stock expert Brandon Clay.

In his Invest with an Edge he suggests, "Maicrosoft's war chest of cash and their ability to sparkle with products like Bing makes the company an attractive long-term bet." Here's the advisor's review.

"Microsoft was once the kind of stock investors dreamed of owning. Rising thousands of percent from its IPO in the mid-1980s to the late 1990s, Microsoft was at one point the largest U.S. company by market cap.

"As technology evolved and Microsoft matured, Wall Street turned its focus to 'sexier' areas of technology like Internet stocks. Operating system software wasn't the in-thing anymore. Microsoft became a value stock rather than a growth play.

"Health care reform could mean opportunities for astute investors," says Brandon Clay in his Invest With an Edge.

Here, eyes two biotech ETFs that "should be on everyone's watch list." The advisor notes, "With health care on the front burner in Washington, these biotechnology ETFs may finally be ready to pop."

"Investors in health care should think outside the realm of traditional pharmaceutical companies and health insurers. Those sectors are each facing headwinds that make stock picking difficult.

"In addition, several big pharma companiesare desperate to reload their empty pipelines in the face of increased competition from generic drug makers.

"Certain commodities are getting hot again; both copper and gold have the wind at their backs in this market, while uranium has also caught our attention," says Brandon Clay.

In his Invest with an Edge, he explains, "One such company that should gain from a spike in gold, uranium, and copper is Vancouver-based Fronteer Development Group (NYSE: FRG).

"Uranium is a perennially despised substance with a back story in catastrophe, espionage, protests, and nuclear fallout. But this sometimes-sordid history may prove too weak an objection for the outstanding potential in uranium.

"Who will gain from the ongoing troubles at the Big-3 automakers in the US?" asks growth stock specialist Brandon Clay.

In his Invest with an Edge, the growth stock advisors takes a look at Tata Motors Ltd. (NYSE: TTM) which is expected to launch the world's cheapest car. Here's the advisor's review.

"Tata Motors is part of one of the largest manufacturing entities on the planet, will soon release the world's cheapest automobile in the United States.

"Debuting at $2000, the Tata Nano is set for a July 2009 delivery. Tata already has 1 million reservations for their mini-car. If they could deliver, it would easily become the best-selling car this year.

"Now could be your chance to pick up Coinstar (NASDAQ: CSTR) at a bargain," Brandon Clay pointing to the firm whose macbhines turn coins into cash. In his Invest with an Edge he states, "We recommend the stock as a recession-resistant, consumer play in a shaky market."

"There are three reasons why we like Constar. First, it's a consumer-savvy play. The company is built on perennial consumer-driven services.

"Their flagship Coinstar machine turns idle change into cash. For every dollar consumers drop into the grate, Coinstar makes $0.089. It may not seem like much, but this simple idea grew CSTR from an idea in 1992, to a $912 million company last year.

This post is part of a 12-article feature that can be read here: Today's best income ideas.

"Though all the king's horses and all the king's men attempted to piece together some confidence in the market indexes, it hasn't been enough," says Brandon Clay.

In his Invest with an Edge, he suggests, "Investors should consider safe alternatives for this risky environment. One such ideas is a unique muni bond ETF -- Market Vectors Pre-Refunded Municipal Index Fund (NYSE: PRB)."

Two leading growth stock expert, Brandon Clay, editor of Invest with an Edge, and Alexander Green, editor of The Oxford Club, turn to automated blood testing equipment maker Immucor (NASDAQ: BLUD) as a recession-resistant buy.

Clay suggest, "A good bet is to go with the strongest stock in that particular sector at the time of your pickThat way, the company you select at least has the momentum of the sector backing it. Typically the medical industry performs better than the overall market in a downturn. This recession has been no different.

"As we dug deeper into health care, one company surfaced that was worth our attention. Immucor is a blood testing equipment manufacturer specializing in pre-transfusion diagnostics.

"Established in 1982, they brought their first patent to market four years later. Since then they've become a leader in blood diagnostics and blood bank technology.

"If you're going to stay invested, you should look to defensive sectors," explain Ron Rowland and Brandon Clay, who point to consumer staples as a top pick for the current market environment.

In their Invest with an Edge, the advisors explain, "Perhaps the best way to stay defensive is with the Consumer Staples Select Sector SPDR (NYSE: XLP), an exchange traded fund.

"In a bear market, opportunities are usually limited to certain sectors. Surveying the investment horizon, we think the consumer staples sector has the best opportunity for growth in this economy.

"Regardless how the economy acts, people still eat. Consumers may not shop at Whole Foods, but they'll still buy groceries. Companies like Wal-Mart (NYSE: WMT) and Safeway (NYSE: SWY) will continue to rake in revenues from hungry customers.

"In addition, these companies should continue to receive additional revenue from consumers who normally shop at specialty stores, but can no longer afford to.

"Consumers may not be shopping at Sharper Image any more, but there are other creature comforts that will be difficult for Americans to abandon.

"Coca-Cola (NYSE: KO) and PepsiCo (NYSE: PEP) will still sell products during a prolonged downturn. In addition, companies providing toiletries and convenience like Procter and Gamble and CVS Pharmacy stand to do well during a shifty economy.